首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   16515篇
  免费   1005篇
  国内免费   263篇
耳鼻咽喉   321篇
儿科学   261篇
妇产科学   157篇
基础医学   2772篇
口腔科学   281篇
临床医学   1276篇
内科学   3481篇
皮肤病学   738篇
神经病学   1159篇
特种医学   1230篇
外科学   2157篇
综合类   35篇
现状与发展   1篇
一般理论   1篇
预防医学   474篇
眼科学   445篇
药学   1552篇
中国医学   250篇
肿瘤学   1192篇
  2024年   6篇
  2023年   84篇
  2022年   290篇
  2021年   599篇
  2020年   308篇
  2019年   440篇
  2018年   527篇
  2017年   428篇
  2016年   678篇
  2015年   865篇
  2014年   1052篇
  2013年   1052篇
  2012年   1718篇
  2011年   1586篇
  2010年   980篇
  2009年   831篇
  2008年   1040篇
  2007年   932篇
  2006年   773篇
  2005年   753篇
  2004年   585篇
  2003年   447篇
  2002年   443篇
  2001年   214篇
  2000年   211篇
  1999年   157篇
  1998年   77篇
  1997年   62篇
  1996年   55篇
  1995年   30篇
  1994年   45篇
  1993年   32篇
  1992年   55篇
  1991年   53篇
  1990年   47篇
  1989年   58篇
  1988年   36篇
  1987年   37篇
  1986年   28篇
  1985年   25篇
  1984年   14篇
  1983年   9篇
  1982年   8篇
  1981年   12篇
  1980年   18篇
  1979年   18篇
  1978年   9篇
  1977年   9篇
  1975年   5篇
  1967年   4篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.

Background and aims

It is not known whether non alcoholic fatty liver disease (NAFLD) is a risk factor for diabetes in non obese, non centrally-obese subjects. Our aim was to investigate relationships between fatty liver, insulin resistance and a biomarker score for liver fibrosis with incident diabetes at follow up, in subjects who were neither obese nor centrally-obese.

Methods and results

As many as 70,303 subjects with a body mass index (BMI) < 25 kg/m2 and without diabetes were followed up for a maximum of 7.9 years. At baseline, fatty liver was identified by liver ultrasound, insulin resistance (IR) by homeostatic model assessment of insulin resistance (HOMA-IR) ≥2.0, and central obesity by waist circumference (waist circumference ≥90 cm (men) and ≥85 cm (women). The Fibrosis-4 (FIB-4 score) was used to estimate extent of liver fibrosis. Cox proportional hazards models adjusted for confounders were used to estimate hazard ratios (aHRs) for incident diabetes. As many as 852 incident cases of diabetes occurred during follow up (median [IQR] 3.71 [2.03] years). Mean ± SD BMI was 22.8 ± 1.8 and 21.7 ± 2.0 kg/m2 in subjects with and without diabetes at follow up. In subjects without central obesity and with fatty liver, aHRs (95% CI) for incident diabetes at follow up were 2.17 (1.56, 3.03) for men, and 2.86 (1.50,5.46) for women. Similar aHRs for incident diabetes occurred with fatty liver, IR and the highest quartile of FIB-4 combined, in men; and there was a non significant trend toward increased risk in women.

Conclusions

In normal weight, non-centrally obese subjects NAFLD is an independent risk factor for incident diabetes.  相似文献   
8.
ABSTRACT

Genotoxic compounds may be detoxified to non-genotoxic metabolites while many pro-carcinogens require metabolic activation to exert their genotoxicity in vivo. Standard genotoxicity assays were developed and utilized for risk assessment for over 40 years. Most of these assays are conducted in metabolically incompetent rodent or human cell lines. Deficient in normal metabolism and relying on exogenous metabolic activation systems, the current in vitro genotoxicity assays often have yielded high false positive rates, which trigger unnecessary and costly in vivo studies. Metabolically active cells such as hepatocytes have been recognized as a promising cell model in predicting genotoxicity of carcinogens in vivo. In recent years, significant advances in tissue culture and biological technologies provided new opportunities for using hepatocytes in genetic toxicology. This review encompasses published studies (both in vitro and in vivo) using hepatocytes for genotoxicity assessment. Findings from both standard and newly developed genotoxicity assays are summarized. Various liver cell models used for genotoxicity assessment are described, including the potential application of advanced liver cell models such as 3D spheroids, organoids, and engineered hepatocytes. An integrated strategy, that includes the use of human-based cells with enhanced biological relevance and throughput, and applying the quantitative analysis of data, may provide an approach for future genotoxicity risk assessment.  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号